Therefore, this study suggests that TM4SF5-dependent protective effects are important for IPF development (Fig. 5j), and further proposes TM4SF5 and CD44v8-10 as promising therapeutic targets against IPF. The gene discussed is TM4SF5; the disease is idiopathic pulmonary fibrosis.